Skip to main content
Medical information Clinical review pending

Genetic Testing

KLF1 Gene Lutheran Inhibitor Blood Group Genetic Test

Genetic test analyzing the KLF1 gene to understand Lutheran blood group characteristics and associated risks.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample, Extracted DNA, or One drop of blood on an FTA card.
Results
3 to 4 Weeks. Confirm with the laboratory before booking.
Preparation
A clinical history of the patient is required. A genetic counseling session to draw a pedigree chart of family members affected with the KLF1 gene is recommended.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the KLF1 Gene Lutheran Inhibitor Blood Group Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of blood group disorders
  • ✓Unexplained hemolytic reactions
  • ✓Patients requiring blood transfusions
  • ✓Genetic counseling for family planning
  • ✓Understanding blood group characteristics
02

In plain language

What this test helps you understand

Identifies genetic variations in the KLF1 gene associated with Lutheran blood group antigens, aiding in understanding potential risks related to blood transfusions and hemolytic disease.
The KLF1 Gene Lutheran Inhibitor Blood Group NGS Genetic DNA Test is a specialized genetic analysis that helps understand blood group characteristics. This test uses Next Generation Sequencing (NGS) technology to identify variations in the KLF1 gene, which is important for forming certain blood group antigens. Understanding your genetic makeup related to blood groups can provide valuable insights into your hematological health and potential risks associated with blood group disorders. This test measures genetic variations in the KLF1 gene that influence Lutheran blood group antigens. Analyzing these markers helps healthcare providers understand an individual's blood group profile and potential risks related to blood transfusions or hemolytic disease. Consulting with a healthcare professional or genetic counselor is essential to interpret the results accurately and understand their implications for your health and family.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationA clinical history of the patient is required. A genetic counseling session to draw a pedigree chart of family members affected with the KLF1 gene is recommended.
SampleBlood sample, Extracted DNA, or One drop of blood on an FTA card.
MethodologyNext Generation Sequencing (NGS) technology is used to analyze the KLF1 gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific variations in the KLF1 gene. It may not detect all possible genetic variations related to blood group characteristics. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The KLF1 gene provides instructions for making a protein that is important for the development of blood cells and the formation of certain blood group antigens.
This test helps identify genetic variations that can affect blood group characteristics, which is important for safe blood transfusions and understanding potential health risks.
Individuals with a family history of blood group disorders, those experiencing transfusion reactions, or those seeking genetic counseling may benefit from this test.
Results are provided in a comprehensive report. It is crucial to discuss the results with a healthcare professional or genetic counselor for accurate interpretation and guidance.
A blood sample, extracted DNA, or a single drop of blood on an FTA card is required for the test.
The typical turnaround time is 3 to 4 weeks. Confirm with the laboratory before booking.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp